Company
Ascendis Pharma A/S
Ascendis Pharma A/S has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Dual therapy with navepegritide and lonapegsomatropin | Phase 3 | Achondroplasia |
Latest
No recent events.
Follow Ascendis Pharma A/S on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.